Santen Pharmaceutical Co (JP:4536) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Santen Pharmaceutical Co. has successfully repurchased 3,729,200 common shares totaling over 6.29 billion yen as part of its share buyback program implemented in November 2024. The buyback is a strategic move to enhance shareholder value, with a maximum target of 5 million shares and a budget of 10 billion yen set by the company.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.